- Home
- MCRB vs TRX Comparison
MCRB vs TRX Comparison
Compare MCRB & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- TRX
- Stock Information
- Founded
- MCRB 2010
- TRX 1990
- Country
- MCRB United States
- TRX Canada
- Employees
- MCRB N/A
- TRX N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- TRX
- Sector
- MCRB Health Care
- TRX
- Exchange
- MCRB Nasdaq
- TRX Nasdaq
- Market Cap
- MCRB 81.2M
- TRX 81.1M
- IPO Year
- MCRB 2015
- TRX N/A
- Fundamental
- Price
- MCRB $7.06
- TRX $0.32
- Analyst Decision
- MCRB Hold
- TRX Strong Buy
- Analyst Count
- MCRB 5
- TRX 1
- Target Price
- MCRB $73.67
- TRX $1.50
- AVG Volume (30 Days)
- MCRB 146.8K
- TRX 697.3K
- Earning Date
- MCRB 05-07-2025
- TRX 04-14-2025
- Dividend Yield
- MCRB N/A
- TRX N/A
- EPS Growth
- MCRB N/A
- TRX N/A
- EPS
- MCRB 0.03
- TRX N/A
- Revenue
- MCRB N/A
- TRX $45,405,000.00
- Revenue This Year
- MCRB N/A
- TRX $67.54
- Revenue Next Year
- MCRB N/A
- TRX $31.56
- P/E Ratio
- MCRB $213.09
- TRX N/A
- Revenue Growth
- MCRB N/A
- TRX 26.50
- 52 Week Low
- MCRB $7.18
- TRX $0.27
- 52 Week High
- MCRB $30.60
- TRX $0.49
- Technical
- Relative Strength Index (RSI)
- MCRB 33.07
- TRX 52.89
- Support Level
- MCRB $8.92
- TRX $0.30
- Resistance Level
- MCRB $9.97
- TRX $0.33
- Average True Range (ATR)
- MCRB 1.08
- TRX 0.02
- MACD
- MCRB -0.06
- TRX -0.00
- Stochastic Oscillator
- MCRB 10.61
- TRX 50.25
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.